Restricted accessResearch articleFirst published online 2002-07
The development of a clinical syndrome of asymptomatic pancreatitis and eosinophilia after treatment with clozapine in schizophrenia: implications for clinical care,recognition and management
Clozapine, the first atypical antipsychotic, is indicated for the treatment of therapy-resistant schizophrenia. It needs to be monitored closely because of its well-known potential side-effects, especially agranulocytosis. We present a case of a middle-aged woman with chronic schizophrenia, who was treated with clozapine and developed a clinical syndrome of asymptomatic pancreatitis and eosinophilia within the fifth week of treatment. Asymptomatic pancreatitis has rarely been reported up to now and is not recognized as a typical side-effect of clozapine. In our opinion, pancreatic enzymes should be monitored especially in the first 6 weeks of clozapine treatment.
Bergemann N, Ehrig C H, Diebold K, Mundt C H, Einsiedel R V (1999) Asymptomatic pancreatitis associated with clozapine. Pharmacopsychiatry32: 78–80
2.
Cerulli T R (1999) Clozapine-associated pancreatitis. Hav Rev Psychiatry7: 61–63
3.
Chatterton R (1997) Eosinophilia after commencement of clozapine treatment. Aust NZ J Psychiatry31: 874–876
4.
Frankenburg F R, Kando J (1992) Eosinophilia, clozapine, and pancreatitis. Lancet340: 251-251
5.
Galletly C, Wilson D, McEwen S (1996) Eosinophilia associated with decreasing neutrophil count in a clozapine-treated patient. J Clin Psychiatry57: 40–41
6.
Gatto E M, Castronuovo A P, Uribe Roca M C (1998) Clozapine and pancreatitis. Clin Neuropharmacol21: 203-203
7.
Jubert P (1994) Clozapine-related pancreatitis. Ann Intern Med121: 722–733
8.
Lucht M J, Rietschel M (1998) Clozapine-induced eosinophilia: subsequent neutropenia and corresponding allergic mechanisms. J Clin Psychiatry59: 195–197
